who invented retatrutide 10 mg — research material — PEPerchini Scientific A new clinical trial from

Acute increases in serum colonic short-chain fatty acids elicited by inulin do not increase GLP-1 or PYY responses but may reduce ghrelin in lean and overweight humans

Let it dry

Retatrutide-Specific Side Effects (TRIUMPH-4, December 2025) Nausea: 38-43% (dose-dependent, mostly during step-up)

Place of GLP-1RAs in the Treatment of Obesity Currently, pharmacotherapy is recommended as an adjunct to lifestyle modification for individuals with a BMI of at least 30 kg/m 2 , or at least 27 kg/m 2 with comorbidity [5, 9]

In fact, early research suggests that GLP-1 receptor agonists may decrease the risk of obesity-associated cancers

Keep portions reasonable, especially if you're prone to nausea